Plaque Psoriasis
📧 Sign up to get email alerts when something new happens for Plaque Psoriasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Efficacy, Safety, Pharmacokinetics of ICP-488 in Patients With Moderate to Severe Plaque Psoriasis [Phase 3]
A Phase 3 clinical trial is evaluating ICP-488 in adults with moderate to severe plaque psoriasis, assessing efficacy, safety, and pharmacok…
-
CLINICAL_TRIALS trial_result · 2026-02-05Clinical Trial Update: A Study to Investigate the Safety and Tolerability of CAN10 Antibody in Healthy Subjects and in Subjects With Plaque Psoriasis. [Phase 1]
A Phase 1 study evaluating the safety and tolerability of the CAN10 antibody in healthy subjects and in people with plaque psoriasis has com…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: A Real-World Study on the Impact of Weight Loss on Treatment Efficacy in Overweight/Obese Patients With Plaque Psoriasis
A real-world study examining whether weight loss influences treatment efficacy in overweight/obese patients with plaque psoriasis; the study…
-
CLINICAL_TRIALS trial_result · 2026-01-30Clinical Trial Update: Treatment of Moderate to Severe Plaque Psoriasis [Phase 2]
This document notes the completion of a Phase 2 clinical trial evaluating an investigational therapy for moderate to severe plaque psoriasis…
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: A Phase I Clinical Trial of Single Subcutaneous Injection or Intravenous Infusion of SHR-1139 Injection in Healthy Chinese Subjects and Multiple Subcutaneous Injections in Patients With Moderate-to-severe Plaque Psoriasis [Phase 1]
Phase I trial evaluating a single subcutaneous or intravenous dose of SHR-1139 in healthy Chinese subjects and multiple subcutaneous doses i…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: Vunakizumab Combined With Recaticimab in Subjects With Moderate to Severe Plaque Psoriasis and Dyslipidemia [Phase 4]
Phase 4 clinical trial evaluating the combination of vunakizumab and recaticimab for moderate to severe plaque psoriasis with dyslipidemia; …
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: A Phase III Trial To Evaluate The Efficacy And Safety Of MC2-01 Cream Compared To CAL/BDP Gel and Vehicle In Plaque Psoriasis Subjects [Phase 3]
Phase 3 study evaluating MC2-01 Cream for plaque psoriasis, comparing it with CAL/BDP Gel and vehicle, is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-23Clinical Trial Update: Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis [Phase 3]
Open-label Phase 3 trial assessing the safety and efficacy of ponesimod for moderate-to-severe chronic plaque psoriasis; the study is not ye…
-
CLINICAL_TRIALS trial_result · 2026-01-20Clinical Trial Update: To Assess the Effect of SCD-044 Treatment on Moderate to Severe Plaque Psoriasis [Phase 2]
Phase 2 study evaluating SCD-044 for moderate to severe plaque psoriasis has completed and results have been posted.
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight [Phase 3]
A Phase 3 trial evaluating concomitant ixekizumab with tirzepatide in adults with plaque psoriasis and obesity is currently active but not r…
-
CLINICAL_TRIALS trial_result · 2026-01-15Clinical Trial Update: A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis [Phase 3]
Phase 3 evaluation of TAK-279 for moderate-to-severe plaque psoriasis; the trial is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: To Check Comparison of Apremilast and Methotrexate Efficacy in Patients With Moderate to Severe Plaque Psoriasis Presented to Tertiary Care Hospital [EARLY_Phase 1]
This clinical trial update describes an early Phase 1 study comparing apremilast versus methotrexate for efficacy in adults with moderate to…
-
FDA approval · 2026-01-07FDA Approved: YESINTEK — Supplemental Application (Biocon Biologics Inc.)
The FDA approved a supplemental application for YESINTEK (ustekinumab) from Biocon Biologics Inc. The action relates to the ustekinumab bios…
-
CLINICAL_TRIALS trial_result · 2026-01-05Clinical Trial Update: A Study to Investigate Efficacy and Safety of Apremilast 30 mg Twice Daily (BID) in Chinese Participants With Moderate to Severe Plaque-type Psoriasis (PsO) [Phase 3]
Phase 3 trial evaluating apremilast 30 mg twice daily in Chinese adults with moderate to severe plaque psoriasis has been completed, assessi…
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: Study to Compare Pharmacokinetics and Safety of CT-P52 and US-licensed Taltz in Healthy Subjects [Phase 1]
A Phase 1 study comparing pharmacokinetics and safety of Celltrion's CT-P52 against US-licensed ixekizumab (Taltz) in healthy participants.
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: Efficacy and Safety of ICP-332 Versus Placebo in Participants With Moderate to Severe Plaque Psoriasis [Phase 2]
A Phase 2 clinical trial update evaluating the efficacy and safety of ICP-332 versus placebo in adults with moderate to severe plaque psoria…
-
CLINICAL_TRIALS trial_result · 2025-12-30Clinical Trial Update: A Study of JNJ-77242113 in Participants With Moderate-to-severe Plaque Psoriasis [Phase 2]
Phase 2 study of JNJ-77242113 in adults with moderate-to-severe plaque psoriasis has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-12-29Clinical Trial Update: A Real-world Study to Assess Safety and Effectiveness of Secukinumab in Pediatric Plaque Psoriasis Patients in China
A real-world study evaluating the safety and effectiveness of secukinumab in pediatric patients with plaque psoriasis in China has completed…
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: Secukinumab Drug Survival, Effectiveness and Tolerability in Pediatric Patients With Psoriasis
Clinical trial update on secukinumab examining drug survival, effectiveness and tolerability in pediatric patients with moderate-to-severe p…
-
FDA approval · 2025-12-23FDA Approved: OTEZLA — Supplemental Application (Amgen, Inc)
FDA approved a supplemental application for OTEZLA (apremilast) from Amgen, Inc. The approval updates the labeling for the product.
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: A Study to Evaluate Efficacy and Safety of IBI112 in Adolescent Participants With Moderate to Severe Plaque Psoriasis [Phase 3]
This clinical trial update describes a Phase 3 study evaluating the efficacy and safety of IBI112 in adolescent participants with moderate t…
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: A Study to Assess the Efficacy and Safety of Apremilast in Japanese Pediatric Participants With Moderate to Severe Plaque Psoriasis [Phase 3]
This is a Phase 3 clinical trial update evaluating the efficacy and safety of apremilast in Japanese pediatric participants with moderate to…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: A Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque Psoriasis [Phase 3]
Takeda is conducting a Phase 3 trial comparing Zasocitinib (TAK-279) with deucravacitinib in adults with plaque psoriasis. The study status …
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: Study Comparing Tapinarof Cream 1% To VTAMA ® (Tapinarof Cream 1%) In the Treatment of Plaque Psoriasis [Phase 3]
Phase 3 study evaluating Tapinarof Cream 1% versus VTAMA for plaque psoriasis has completed.
-
EMA approval · 2025-12-16EMA Authorised: Erelzi (etanercept) — Sandoz GmbH
The EMA authorised Erelzi (etanercept) by Sandoz GmbH as a biosimilar to treat several inflammatory conditions including rheumatoid arthriti…